메뉴 건너뛰기
Acta Oncologica
Volumn 50, Issue 4, 2011, Pages 578-581
Bevacizumab-induced nasal septal perforation: Incidence of symptomatic, confirmed event(s) in colorectal cancer patients
Author keywords

[No Author keywords available]
Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;
EID: 79955620845     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.537692     Document Type: Article
Times cited : (13)
References (9)
  • 1
    • 77956426922 scopus 로고    scopus 로고
    • Nasal septum perforation: A side effect of bevacizumab chemotherapy in breast cancer patients
    • Baldini C, Van JT, Servent V, Mallet Y, Bonneterre J. Nasal septum perforation: A side effect of bevacizumab chemotherapy in breast cancer patients. Br J Cancer 2010; 103:772-5.
    • (2010) Br J Cancer , vol.103 , pp. 772-5
    • Baldini, C.1    Van, J.T.2    Servent, V.3    Mallet, Y.4    Bonneterre, J.5
  • 3
    • 34147190880 scopus 로고    scopus 로고
    • FDA drug approval summary: Bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer
    • DOI 10.1634/theoncologist.12-3-356
    • Cohen MH, Gootenberg J, Keegan P, Pazdur R. FDA drug approval summary: Bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer. Oncologist 2007; 12:356-61. (Pubitemid 46556802)
    • (2007) Oncologist , vol.12 , Issue.3 , pp. 356-361
    • Cohen, M.H.1    Gootenberg, J.2    Keegan, P.3    Pazdur, R.4
  • 4
    • 31444448742 scopus 로고    scopus 로고
    • Bevacizumab-induced nasal septum perforation
    • Fakih MG, Lombardo JC. Bevacizumab-induced nasal septum perforation. Oncologist 2006;11:85-6.
    • (2006) Oncologist , vol.11 , pp. 85-6
    • Fakih, M.G.1    Lombardo, J.C.2
  • 5
    • 79952244977 scopus 로고    scopus 로고
    • Nasal septum perforation and bevacizumab
    • Epub Mar 6
    • Power DG, Kemeny NE. Nasal septum perforation and bevacizumab. Med Oncol. Epub 2010 Mar 6.
    • (2010) Med Oncol.
    • Power, D.G.1    Kemeny, N.E.2
  • 6
    • 33751202424 scopus 로고    scopus 로고
    • Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer
    • DOI 10.1634/theoncologist.11-10-1070
    • Traina TA, Norton L, Drucker K, Singh B. Nasal septum perforation in a bevacizumab-treated patient with metastatic breast cancer. Oncologist 2006;11:1070-1. (Pubitemid 44788397)
    • (2006) Oncologist , vol.11 , Issue.10 , pp. 1070-1071
    • Traina, T.A.1    Norton, L.2    Drucker, K.3    Singh, B.4
  • 7
    • 34548250511 scopus 로고    scopus 로고
    • Invasive fungal infection and nasal septum perforation with bevacizumab-based therapy in advanced colon cancer
    • DOI 10.1200/JCO.2007.12.0006
    • Ruiz N, Fernandez-Martos C, Romero I, Pla A, Maiquez J, Calatrava A, et al. Invasive fungal infection and nasal septum perforation with bevacizumab-based therapy in advanced colon cancer. J Clin Oncol 2007;25:3376-7. (Pubitemid 47325627)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.22 , pp. 3376-3377
    • Ruiz, N.1    Fernandez-Martos, C.2    Romero, I.3    Pla, A.4    Maiquez, J.5    Calatrava, A.6    Guillem, V.7
  • 8
    • 51649118405 scopus 로고    scopus 로고
    • Spontaneous nasal septal perforation with antiangiogenic bevacizumab therapy
    • Burkart CM, Grisel JJ, Hom DB. Spontaneous nasal septal perforation with antiangiogenic bevacizumab therapy. Laryngoscope 2008;118:1539-41.
    • (2008) Laryngoscope , vol.118 , pp. 1539-41
    • Burkart, C.M.1    Grisel, J.J.2    Hom, D.B.3
  • 9
    • 71049169180 scopus 로고    scopus 로고
    • Nasal septum perforation in a breast cancer patient treated with bevacizumab
    • Marin AP, Sanchez AR, Arranz EE. Nasal septum perforation in a breast cancer patient treated with bevacizumab. Ann Oncol 2009;20:1901-2.
    • (2009) Ann Oncol , vol.20 , pp. 1901-2
    • Marin, A.P.1    Sanchez, A.R.2    Arranz, E.E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.